The doctor-patient relationship in the generative AI era

Five reasons why the time to act for pharma is now.

Ipsos | Ipsos views | Healthcare | Generative AI Generative AI is revolutionizing the medical advice landscape, redefining the doctor-patient dynamic in ways previously unimaginable. This brings both huge opportunities and formidable challenges.

Drawing on new research among healthcare professionals, along with our vast experience in this field, we explore these potential impacts in detail.

We also consider the implications for pharmaceutical companies, providing five key reasons why the time for action is now.

We conclude with an incontestable truth: this is a high-risk, high-reward field and the companies that take the lead stand to reap the most significant benefits.

Download our paper

Download

Related news

  • [WEBINAR] KEYS: The Middle Class in Crisis?
    Consumers Webinar

    [WEBINAR] KEYS: The Middle Class in Crisis?

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • [WEBINAR] Canadian EV Adoption Trends in 2025
    Society Webinar

    [WEBINAR] Canadian EV Adoption Trends in 2025

    Join us on February 26 for our next Western Canada Lunch & Learn Insights series as Ipsos experts share the latest research on the dynamic world of EVs
  • [WEBINAR] Sustainable Packaging: A Potential Avenue of Distinction
    Sustainability Webinar

    [WEBINAR] Sustainable Packaging: A Potential Avenue of Distinction

    In this next session from our ESG series, Ipsos’ Dionne Daley will discuss the role of sustainable packaging in innovation. Learn how Ipsos goes deeper to better understand your brand’s consumers, what will resonate best with them, and how you can explore sustainable packaging as a potential avenue of distinction; a critical component for in-market success.